Huang, Sheng-Tung <br/><br/>
Development and biological evaluation of C(60) fulleropyrrolidine-thalidomide dyad as a new anti-inflammation agent.  [electronic resource] 

 -  Bioorganic & medicinal chemistry  Sep 2008 
 - 8619-26 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3391 
<br/><br/><label>Standard No.: </label>10.1016/j.bmc.2008.08.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anti-Inflammatory Agents--chemical synthesis<br/>Cell Survival<br/>Cells, Cultured<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Fullerenes--chemistry<br/>Lipopolysaccharides<br/>Macrophages--drug effects<br/>Nitric Oxide--antagonists & inhibitors<br/>Nitric Oxide Synthase Type II--genetics<br/>Phosphorylation--drug effects<br/>Pyrrolidines--chemical synthesis<br/>Reactive Oxygen Species--antagonists & inhibitors<br/>Thalidomide--analogs & derivatives<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors